Steph & Co’s Gossamer Bio GOSS Stock Holding History

Steph & Co’s Portfolio GOSS Stock Details GOSS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-313	Closed	-$22.6K	–	270
2024 Q4	$22.6K	Buy	313 +63	+25%	+$4.32K	0.01%	205
2024 Q3	$19.7K	Buy	+250	New	+$19.2K	0.01%	226

Other funds holding GOSS

OCA

Octagon Capital Advisors New York $1.11B AUM 866.76% 1-Year Est. Return

NMC

NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

AVM

Arch Venture Management Chicago, Illinois $1.1B AUM 356.62% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

SCM

Silverarc Capital Management Boston, Massachusetts $962M AUM 524.64% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return

Samsara BioCapital Palo Alto, California $1.22B AUM 242.83% 1-Year Est. Return

6CM

683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return

Steph & Co's GOSS Position: Q1 2025 in Review

Steph & Co sold out of Gossamer Bio (GOSS) in Q1 2025, closing a stake of 313 shares — an estimated $22.6K sold.

Steph & Co first reported a position in GOSS in Q3 2024 and held it in 2 quarters. The position peaked at $22.6K in Q4 2024. 116 funds tracked by Wall St. Rank hold GOSS as of Q1 2025.

Steph & Co reported no remaining Gossamer Bio position as of Q1 2025 after selling out during the quarter.
Steph & Co sold 313 Gossamer Bio shares in Q1 2025, an estimated $22.6K.
Steph & Co first reported a position in Gossamer Bio in Q3 2024 and held it in 2 quarters.
Steph & Co's Gossamer Bio position peaked at $22.6K in Q4 2024.
116 funds tracked by Wall St. Rank held Gossamer Bio as of Q1 2025.

Based on Steph & Co's 13F filing for Q1 2025, filed 23 Apr 2025.